ClinicalTrials.Veeva

Menu

No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Begins enrollment in 11 months

Conditions

Elevated Blood Pressure
Perimenopause

Treatments

Behavioral: Physical activity intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06376812
23-0320

Details and patient eligibility

About

This study will test the effects of a physical activity intervention among midlife Hispanic women.

Full description

The menopausal transition in midlife is a critical juncture where women experience life transitions and adverse physiological and psychological changes that increase the risk for hypertension and cardiovascular diseases in later life. Physical activity improves blood pressure, biomarkers of hypertension, sleep, mood, and well-being; however, Hispanic women meet physical activity recommendations at lower levels than non-Hispanic White women. The investigator will examine the feasibility of the physical activity intervention among sedentary midlife Hispanic women in the menopausal transition with elevated blood pressure, exploring changes in physical activity and health.

Enrollment

40 estimated patients

Sex

Female

Ages

45 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Female
  2. Hispanic by self-report
  3. Able to speak and read English
  4. Sedentary
  5. Age 45-50
  6. Diagnosed with elevated blood pressure or objectively measured systolic blood pressure 120-139 mmHg and/or diastolic blood pressure 80-89 mmHg averaged from ≥ 2 measures on ≥ 2 outpatient visits
  7. Symptoms consistent with the menopause transition (persistent difference of ≥7 days in the length of consecutive cycles; persistence is defined as recurrence within 10 cycles of the first variable length cycle)
  8. Apparently healthy
  9. Self-reported ability to engage in moderate intensity physical activity
  10. Access to a smart device that is compatible with a Fitbit application

Exclusion criteria

  1. Self-reported physical activity of ≥150 minutes per week
  2. Answered yes to any question on the Physical Activity Readiness (PAR-Q+) questionnaire
  3. Post-menopausal (12-months without a menstrual cycle)
  4. Diagnosed hypertension
  5. Cardiovascular, respiratory, neurological, renal, endocrine, gastrointestinal and/or psychiatric diseases, or any cancers
  6. Previous hysterectomy, oophorectomy, and/or uterine ablation
  7. Medication to treat hypertension, elevated glucose, cholesterol, depression, anxiety, and insomnia
  8. Hormonal medication via any route or implants
  9. Tamoxifen
  10. Pregnant, planning to become pregnant, or breastfeeding
  11. Planning to move out of the Galveston/Houston area in the next 18 months
  12. Current participation in another physical activity study or program

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Physical activity intervention
Experimental group
Description:
Multi-level intervention to increase physical activity
Treatment:
Behavioral: Physical activity intervention

Trial contacts and locations

1

Loading...

Central trial contact

Lisa Thibodeaux, BSN, RNC-OB

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems